
USPH Stock Forecast & Price Target
USPH Analyst Ratings
Bulls say
US Physical Therapy Inc. has demonstrated a sequential increase in commercial pricing of 2.2%, reflecting a stable pricing environment that supports revenue growth. The company's Industrial Injury Prevention (IIP) segment reported a notable revenue increase of 22.2% overall, with an 18.4% increase when excluding contributions from mergers and acquisitions, indicating strong organic growth in this area. Additionally, the recent acquisition of the Metro business has resulted in an improved net rate of $107.50, up from $101, which suggests enhanced profitability potential for the company moving forward.
Bears say
US Physical Therapy has experienced a decline of 0.6% in a key financial metric, dropping from $84.46 to $83.95 year-over-year, indicating a potential trend of stagnation or decline in its revenue growth. The company has also faced ongoing reimbursement cuts over the past five years, amounting to a significant $20 million headwind to profitability, which could severely impact its financial health. Additionally, the ratio of rent, clinic, and other expenses to revenue increased to 20.2%, slightly above estimates, raising concerns about cost management amid these revenue challenges.
This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.
USPH Analyst Forecast & Price Prediction
Start investing in USPH
Order type
Buy in
Order amount
Est. shares
0 shares